Protalix BioTherapeutics, Inc. Current Assets
Protalix BioTherapeutics, Inc. (PLX) had Current Assets of $92.22 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-12
- 2026-06-30: Assets, Current $92.22M.
- 2026-03-31: Assets, Current $86.36M.
- 2025-12-31: Assets, Current $66.67M.
- 2025-09-30: Assets, Current $66.50M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $92.22M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $86.36M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $66.67M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $66.50M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $65.48M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $60.51M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $60.08M 10-K · filed 2026-03-18 |
| 2024-09-30 | $47.85M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $77.37M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $75.40M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $69.93M 10-K · filed 2025-03-17 |
| 2023-09-30 | $72.62M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $73.58M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $55.40M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $44.88M 10-K · filed 2024-03-14 |
| 2022-09-30 | $45.76M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $49.70M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $56.54M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $61.67M 10-K · filed 2023-02-27 |
| 2021-09-30 | $71.22M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $95.92M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $90.70M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $55.72M 10-K · filed 2022-03-31 |
| 2020-09-30 | $60.33M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $54.21M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $57.77M 10-Q · filed 2020-06-01 |
| 2019-12-31 | $32.48M 10-K · filed 2021-03-30 |
| 2019-09-30 | $40.44M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $41.60M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $47.34M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $52.98M 10-K · filed 2020-03-12 |
| 2018-09-30 | $57.34M 10-Q · filed 2019-03-18 |
| 2018-06-30 | $43.05M 10-Q · filed 2019-03-18 |
| 2018-03-31 | $55.69M 10-Q · filed 2019-03-18 |
| 2017-12-31 | $62.65M 10-Q · filed 2019-03-18 |
| 2017-09-30 | $51.15M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $48.89M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $61.54M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $71.87M 10-K · filed 2018-03-06 |
| 2016-09-30 | $59.65M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $67.64M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $76.27M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $85.88M 10-K · filed 2017-03-16 |
| 2015-09-30 | $47.88M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $53.87M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $59.58M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $65.52M 10-K · filed 2016-03-08 |
| 2014-09-30 | $71.21M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $82.36M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $88.56M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $97.90M 10-K · filed 2015-03-12 |
| 2013-09-30 | $105.20M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $45.93M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $52.89M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $61.17M 10-K · filed 2014-03-13 |
| 2012-09-30 | $59.58M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $65.89M 10-Q · filed 2012-08-03 |
| 2012-03-31 | $49.84M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $32.49M 10-K · filed 2013-02-28 |
| 2011-09-30 | $40.28M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $51.20M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $46.33M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |